Navigation Links
Global Breast Cancer Market 2013: Latest Industry Analysis, Size, Share, Growth, Trends and Forecast Research Report Available at

Albany, NY (PRWEB) July 13, 2013

Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmounting new acmes. The growth of the respective sector is further filliped by the increasing number of health related issues surfacing on account of changing lifestyle and incessantly evolving surroundings.

To cater to the necessity of better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved diagnostic technologies and treatment therapies, especially in the field of breast cancer treatment.

‘Cancer’ is the result of any mutation or abnormal changes in the genes which are responsible for regulating the growth of cells and keeping them healthy. The tumor formed due to cancer can be either ‘benign’ (not dangerous) or ‘malignant’ (potentially dangerous). ‘Breast cancer’ is a malignant tumor that has developed from cells in the breast. Typically breast cancer either begins in the cells of the lobules (milk-producing glands), or the ducts (the passages that drain milk from the lobules to the nipple).

The stages of breast cancer are crucial as they only determine the type of treatment method and the extent to which the disease can be cured.

To Read The Complete Report with TOC :

On the diagnosis front, mammography is believed to diagnose 85% to 90% of breast cancers in women over 50, and is capable of discovering a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue, breast implants or patients who are breastfeeding, mammography cannot produce clear images; therefore, in such cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, the first method to be used is surgical, followed by hormone therapy, chemo therapy or radiation therapy.

To Buy a Copy Of This Report:

After lung cancer, breast cancer is the 2nd most prevalent type of cancer and 5th most common cause of cancer deaths on global scale. Over one million new cases of breast cancer are diagnosed every year world over.

Table of Content

1. Breast Cancer: Overview
1.1 Types of Breast Cancer
1.2 Risk Factors
1.3 Symptoms of Breast Cancer
1.4 Diagnosis and Treatment of Breast Cancer
1.4.1 Breast Cancer Screening and Diagnostic Measures
1.4.2 Breast Cancer Treatment Regime

2. Market Size
2.1 Breast Cancer Statistics
-New Cases
-Estimated Deaths
2.2 Breast Cancer Market Structure

  • Therapeutics Market
-Diagnostics Market
-Market Segmentation
2.2.1 Regional Breast Cancer Markets
-The US
2.3 Breast Cancer Therapeutics Model

3. Market Dynamics
3.1 Industry Trends and Developments
3.1.1 Successive Clinical Trials and Product Development
3.2 Growth Drivers
3.2.1 Increasing Prevalence of Cancer
3.2.2 Increasing Use of Tobacco and Alcohol
3.2.3 Expanding Obese Population
3.2.4 Rising Demand for Better Healthcare Options
3.2.5 Growing Female Population (+45 Years)
3.2.6 Higher Spending on Medicines
3.3 Challenges
3.3.1 Rising Costs of Treatment
3.3.2 Stringent Regulatory Measures
3.3.3 Adverse Effects of the Treatment
3.3.4 Mounting Price Pressure

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz
Blog :

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global Biosensors Market Is Expected to Reach USD 18.9 Billion in 2018 - Transparency Market Research
2. Global Stem Cells Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
3. IMG Add Moratorium Option, Increasing Likelihood of Pre-existing Conditions Cover for Globalsurance Clients
4. Kidpower’s Child Protection Skills And Leadership Training In Bay Area Draws Global Participation - Few Spots Available
5. The Beryl Institute Introduces Global Patient and Family Advisory Council
6. Global bid to bring worlds leading cancer minds to Manchester, UK
7. Global Big Data Market – Size, Share, Forecast, Segments, Opportunity, Report 2012 – 2018
8. Humidity Changes Cause Global Health and Dehydration Crisis Warns Water Researcher Sharon Kleyne
9. Sydneys urban areas to be hit hardest by global warming
10. Synthetic Biology Market is Expected to Reach USD 16.7 Billion Globally in 2018 - Transparency Market Research
11. Sallie Fraenkel Named Executive Vice President of the Global Spa & Wellness Summit
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... Lake, IL (PRWEB) , ... November 25, 2015 , ... ... to announce a recent successful appellate decision obtained by Attorneys Francisco J. Botto and ... case Adcock v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for the ... of the benefits of Botox® in the treatment of moderate facial wrinkling, few have ... pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism (the ...
(Date:11/25/2015)... ... 2015 , ... Beddit® has launched a new Android app for ... features a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and ... created by a proprietary algorithm. Beddit analyzes the data to provide an easy to ...
(Date:11/25/2015)... , ... November 25, 2015 , ... In an ongoing ... Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its ... surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 at ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... November 25, 2015 Kitov Pharma ... (TASE: KTOV), a biopharmaceutical company focused on the development ... clinical conditions, today announced the closing of its previously ... ( ADSs ), each representing 20 ordinary shares of ... ADSs. The ADSs and warrants were issued in a ...
(Date:11/25/2015)... , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: ... today announced that Chief Executive Officer Antonius Schuh, Ph.D., ... 27 th Annual Piper Jaffray Healthcare Conference. ... the New York Palace Hotel in New ... 1:30 p.m. EST. Mr. Schuh will be available for ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
Breaking Medicine Technology: